ILMN Illumina Inc

$101.80

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About Illumina Inc

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.

Website: https://www.illumina.com

Sector
LIFE SCIENCES
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1110803
Address
5200 ILLUMINA WAY, SAN DIEGO, CA, US
Valuation
Market Cap
$11.27B
P/E Ratio
nan
PEG Ratio
0.62
Price to Book
4.75
Performance
EPS
$-7.69
Dividend Yield
Profit Margin
-28.00%
ROE
-30.10%
Technicals
50D MA
$87.04
200D MA
$121.85
52W High
$156.66
52W Low
$68.70
Fundamentals
Shares Outstanding
158M
Target Price
$120.12
Beta
1.38

ILMN EPS Estimates vs Actual

Estimated
Actual

ILMN News & Sentiment

Aug 22, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should Boston Scientific Stock Be in Your Portfolio Right Now?
BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.
Aug 15, 2025 • Benzinga BULLISH
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited - SandRidge Energy ( NYSE:SD ) , JetBlue Airways ( NASDAQ:JBLU ) , Centuri Holdings ( NYSE:CTRI ) , Intl Flavors & Fragrances ( NYSE:IFF )
Icahn boosts Centuri stake 158%, keeps JetBlue and utilities steady. Portfolio shifts favor infrastructure, utilities, and cash flow over cyclical or speculative bets. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.
Aug 15, 2025 • Benzinga SOMEWHAT-BEARISH
NICE Stock Stops Being Nice, Has A Bearish Breakdown - Illumina ( NASDAQ:ILMN ) , NICE ( NASDAQ:NICE )
NICE Ltd. NICE has entered Phase 9 of its 18-phase Adhishthana cycle on the monthly chart, and the technical picture has deteriorated. The stock appears to have broken its Adhishthana Cakra to the downside, a signal that often precedes a long stretch of consolidation and weakness.
Aug 15, 2025 • Zacks Commentary NEUTRAL
TMO Receives FDA Approval for Oncomine Dx Target Test
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
Aug 15, 2025 • Benzinga BULLISH
Cathie Wood's Thursday Bet: ARK Just Bought $31 Million Worth Of Falling Deere Stock, Also Loads Up On Block, Robinhood Shares - ARK Innovation ETF ( BATS:ARKK )
Ark Invest, led by Cathie Wood, made significant trades on Thursday - focusing on Deere & Co. DE, Block Inc. XYZ and Robinhood Markets Inc. HOOD. ArrivedBuy shares of homes and vacation rentals for as little as $100. Get Started WiserAdvisorGet matched with a trusted, local financial advisor for ...
Aug 14, 2025 • Benzinga SOMEWHAT-BULLISH
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer - BioStem Technologies ( OTC:BSEM ) , Illumina ( NASDAQ:ILMN )
POMPANO BEACH, Fla., Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- BioStem Technologies, Inc. ( "BioStem" or the "Company" ) BSEM, a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the ...
Sentiment Snapshot

Average Sentiment Score:

0.163
50 articles with scored sentiment

Overall Sentiment:

Bullish

ILMN Reported Earnings

Apr 30, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
Feb 06, 2025
Dec 31, 2024 (Post market)
-0.06 Surprise
  • Reported EPS: $0.86
  • Estimate: $0.92
  • Whisper:
  • Surprise %: -6.8%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.26 Surprise
  • Reported EPS: $1.14
  • Estimate: $0.88
  • Whisper:
  • Surprise %: 29.6%
Aug 06, 2024
Jun 30, 2024 (Post market)
-0.54 Surprise
  • Reported EPS: $0.36
  • Estimate: $0.90
  • Whisper:
  • Surprise %: -60.0%
May 02, 2024
Mar 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.09
  • Estimate: $0.04
  • Whisper:
  • Surprise %: 125.0%
Feb 08, 2024
Dec 31, 2023 (Post market)
0.12 Surprise
  • Reported EPS: $0.14
  • Estimate: $0.02
  • Whisper:
  • Surprise %: 600.0%
Nov 09, 2023
Sep 30, 2023 (Post market)
0.21 Surprise
  • Reported EPS: $0.33
  • Estimate: $0.12
  • Whisper:
  • Surprise %: 175.0%
Aug 09, 2023
Jun 30, 2023 (Post market)
0.3 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.02
  • Whisper:
  • Surprise %: 1500.0%
Apr 25, 2023
Mar 31, 2023 (Post market)
0.05 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.03
  • Whisper:
  • Surprise %: 166.7%

Financials